“Lewy Body Dementia: The Under-Recognized but Common Foe”

The Dana Foundation has just published a new online article on Lewy Body Dementia. The website’s editor says:

After Alzheimer’s disease, Lewy body dementia (LBD) is the most prevalent progressive dementia of the many cognitive disorders wreaking unspeakable havoc on millions of lives. LBD is characterized by the presence of Lewy bodies, which are abnormal aggregates of a protein called alpha-synuclein, and are found  in regions of the brain that regulate behavior, memory, movement, and personality. Many of the symptoms of Alzheimer’s, Parkinson’s, and LBD overlap, but LBD is more difficult to diagnose. Underdiagnosis is just part of the reason why LBD is unknown to the public and many health-care providers, and why funding for research lags far behind that for almost every other cognitive disorder.

While it’s a good article, I think it would be challenging reading for those who are new to LBD.  Probably most of our group members won’t have a problem with it!

The article makes a few points:

  • The underdiagnosis of LBD may delay appropriate symptomatic treatments and expose patients to dangerous medications.  It also leads to a lack of LBD research.
  • An early diagnosis of LBD helps families prepare.
  • Though the majority of both LBD caregivers and Alzheimer’s caregivers mention “memory impairment” as the most common presenting symptom, the nature of the memory impairment is different“Alzheimer’s affects the ability to encode new experiences into one’s long-term memory, whereas the disorder in LBD can be one that affects retrieval of memory.”
  • “If medications are employed for LBD patients, a complex and delicate degree of balance is required. Drugs that are commonly used to treat the rigidity and immobility of Parkinson’s cannot be used as liberally in dementia with Lewy bodies, since they tend to worsen hallucinations.”

These facts were new to me, and I’ll have to ask around about them:

  • “[The] amount of overall pathology associated with alpha-synuclein occurs at lower levels than amyloid and tau proteins in Alzheimer’s, which makes it harder to develop lab tests that measure it.”
  • “[There] are fewer genetic causes of LBD that can be used to create experimental models than there are of Alzheimer’s.”
  • “It wasn’t until the development of a staining technique in the late 1990s that researchers learned how much more common LBD is than previously thought.”

There are two things that I take issue with in the article.  First and most importantly, with just about all publications about Lewy Body Dementia, there is a co-mingling of two disorders — Dementia with Lewy Bodies, and Parkinson’s Disease Dementia.  These disorders actually have separate diagnostic criteria though you wouldn’t know that from this article or from the Lewy Body Dementia Association website.

Second, RBD (REM sleep behavior disorder) seems to have slipped into being identified as a “core feature” of LBD rather than a “suggestive feature.”  (The diagnostic criteria for DLB lists RBD as a “suggestive feature.”)

Here’s a link to the article:

dana.org/news/cerebrum/detail.aspx?id=44538

Lewy Body Dementia: The Under-Recognized but Common Foe
By Meera Balasubramaniam and James E. Galvin
From:  Dana.org
October 02, 2013

If you pick up on items of interest to you, please share! News about this article was recently posted to an LBD-related online support group.

Robin

Recommended book on DLB/PDD by Dr. Ahlskog – “Patient, Family and Clinician Working Together”

Recently I purchased a book by Eric Ahlskog, MD, PhD, a well-regarded movement disorder specialist at Mayo Rochester.  The book title is “Dementia with Lewy Bodies & Parkinson’s Disease Dementia:  Patient, Family, and Clinician Working Together for Better Outcomes.”

I’ll put it in our support group lending library for someone to borrow at the next support group meeting.  By the way, if you are interested in making an in-kind donation of books to the support group, a non-profit organization, let me know.  Our wish list is long!

I read three chapters today — one on background, one on symptoms/diagnosis, and one on treatment — and skimmed through the rest.  Based on three chapters, I’d say this is a wonderful book.  It contains the precision of a researcher and clinician, but worded in such a way that we laypeople can understand.  I’ve copied a few excerpts below.

There isn’t anything new in the book for me, but I’ve been reading about Lewy body diseases for quite awhile.  There may be new things for you!

Robin

—————————————————————

Excerpts from:

Dementia with Lewy Bodies & Parkinson’s Disease Dementia:  Patient, Family, and Clinician Working Together for Better Outcomes
by Eric Ahlskog, MD, PhD

Background
“The dementia of both DLB and PDD is due to the Lewy body neurodegenerative process.  However, three other factors also contribute, to varying degrees.  By themselves, these other three factors are not the primary causes of dementia in Lewy conditions but are additive…  One such factor is cerebrovascular disease, which may be…unrecognized; it may also manifest as brain atherosclerosis (hardening of the arteries).  Atherosclerosis of small brain arteries is the reason for leukoaraiosis, which is the white blush present to varying extents on the [MRI] brain scans of older adults.  Treating risk factors for such cerebrovascular disease, especially earlier in life, is wise; however, once dementia is present it may be too late.  Such risk factors include hypertension, diabetes mellitus, elevated cholesterol., smoking, and lack of exercise.”

“A second contributor to dementia, but not a major factor in DLB or PDD, is Alzheimer brain pathology…  Such microscopic changes slowly accumulate with aging in most humans, even those without dementia.  In many older adults they are modest and not sufficient to result in dementia.  However, in a brain already challenged with Lewy neurodegenerative pathology, there is little reserve; a small degree of brain Alzheimer pathology will be additive.  Such changes are noted in many, but not all, with DLB or PDD.”

“Finally, contributing to the dementia of DLB and PDD is normal brain aging.  With passing decades of life our brains shrink, which is very apparent on MRI brain scans in those over age 80 years.  This is primarily due to loss of brain connections as part of the aging process.  Although there is a modest, age-related loss of brain cells (neurons), the primary reason for brain shrinkage is loss of synapses and the connecting neuron circuitry (axon terminals, portion of dendrites).  Fortunately, many older adults without Alzheimer’s or Lewy disease are able to compensate for this age-related brain shrinkage, but it is additive if neurodegenerative disorders are present.”

Why and How Do We Distinguish DLB from PDD?
“PDD starts as Parkinson’s disease, which then progresses to include dementia; those with DLB start out with dementia.  Are these just different ends of a single spectrum?  Are they really the same disorder?  This is an unresolved question.”

“Parkinson’s disease is devoid of intellectual problems when it first develops.  In contrast, cognitive impairment is present at the onset of DLB, sometimes with parkinsonism delayed.  In fact, some people with DLB never experience parkinsonism.”

“How do researchers make the distinction? … An international consensus panel has institute the so-called 1-year rule to separate DLB from PDD. … Obviously, this is a little arbitrary, but such distinctions help researchers clearly define what they are studying.  In the clinic, where clinicians deal with real people and their problems, that distinction is less crucial.”

Fluctuations in Thinking and Alertness
“Unique to these Lewy dementias is the fluctuation of mental clarity.  People with DLB or PDD may be alert and lucid during portions of the day, but inexplicably confused several hours later.  This is a hallmark of DLB and PDD.  Daytime drowsiness may similarly fluctuate like this, although there may be other treatable reasons for sleepiness…  The reason for these fluctuations in mental clarity is unknown.”

Neuropsychologist talks about resilience in PD (16 minutes – online audio program)

This post has some tips from a neuropsychologist on developing resilience.  These tips may be of interest to caregivers and those with neurological disorders.

Last year at a July caregivers symposium we helped organize, the keynote speaker focused on resilience.  I think this is a very important topic for us all.  The speaker said that resilience can be learned:  yes, we are born with some basic resilience but we can all learn to expand our resilience.  And the speaker said that social isolation is as deadly to us as smoking is.

Somehow I got put on the email list for Voice Aerobics, which is a Florida-based company that focuses on Parkinson’s Disease (PD).  About a month ago they started using “blog talk radio” as a way to reach a large audience with info about PD and PD organizations.

A recent 30-minute program is on the topic of resilience, with a neuropsychologist, Dr. Jeffrey Wertheimer, speaking.  Though the focus is on Parkinson’s disease (and a survey done with 825 people with PD), I think all of what the neuropsychologist said applies to the four disorders in our support group.  He also believes that we can become more resilience through coping strategies.  One such strategy is not to be isolated.

Here are some highlights of what Dr. Wertheimer said:

  • Resilience is more than a personality trait.  There are tools, strategies, and learned experiences that can help create a sense of resilience.
  • As Parkinson’s progresses, the symptoms may chip away at the feeling of resilience. It’s important that we are aware of this.
  • We need to ask people “did you have your mental health moment today” just as we ask people if they took their medication or did their exercises.
  • Be proactive.  Engage in activities such as exercise.
  • Regard Parkinson’s Disease obstacles as challenges to overcome rather than a hopeless barrier.
  • Learn about illness.
  • Engage in life – hobbies and pleasures.
  • Externalize the distress by sharing it with a psychologist, support group, or friends.

I took a few notes while I was listening, and have copied these below.

Robin

——————————————————————————–

www.blogtalkradio.com/voice-aerobics/2013/08/23/parkinsons-and-resilience-got-it-get-it

Parkinson’s and Resilience: Got it? Get it!
by Voice Aerobics Talking 2 You
30:13 minute program

Robin’s notes from when Jeffrey Wertheimer, PhD, neuropsychologist, is speaking (from about 10:45 to 27:00):

12:05
Defines resilience as a dynamic process whereby individuals cope with and adapt or adjust to stress, challenge, medical illness, or any sort of adversity.

The usual focus is on “what’s wrong.”  Those with Parkinson’s Disease (PD) and their families focus on debilitating symptoms.  We need to also look at what’s going well.

13:55
Asks “how do we get more resilience?”  How we respond to challenges is influenced by personal strengths and resources.  Do we have a positive attitude?

How can we be proactive in coping?

15:00
He talks about the survey on coping.  Intentionally look for ways to live life fully.  Develop a positive attitude.

15:55
Catchy phrase:  where the attention goes, the emotion flows.  The more we focus on adapting, the more resilient we are.

18:00
Discusses depression in PD.  There can be a biological element to depression and anxiety.

20:00
Resilience is more than a personality trait.  There are tools, strategies, and learned experiences that can help create a sense of resilience.

As PD progresses, the symptoms may chip away at the feeling of resilience. It’s important that we are aware of this.

We need to ask people “did you have your mental health moment today” just as we ask people if they took their medication or did their exercises.

Be proactive.  Engage in activities such as exercise.

Regard PD obstacles as challenges to overcome rather than a hopeless barrier.

Learn about illness.

Engage in life – hobbies and pleasures.

Externalize the distress by sharing it with a psychologist, support group, or friends.

26:00
If people have greater levels of support, they have greater levels of perceived resilience.  If someone is isolated, they may be struggling.

Caution against unproven stem cell therapies (Parkinson’s, MSA, etc)

This may be of interest to everyone in our support group, regardless of diagnosis.

The Movement Disorder Society (MDS) issued a position paper this week on the use of stem cell therapies for Parkinson’s Disease (PD).  The lay summary of the position paper concludes as follows:

“[Until] such treatments are proven to be of benefit and published in recognized scientific journals that objectively scrutinize their procedures, the Society encourages patients to participate only in cell therapy studies that are part of a research program affiliated with a recognized academic institution.”

A section of the paper was about stem cell treatment for “parkinsonian syndromes.” This term applies to PD, MSA, PSP, CBD, and DLB.  That section reads:

“Present publicly offered stem cell therapies for clinical use
There are several organizations world-wide which offer stem cell therapy for clinical application in patients. There is no detailed scientific information available on the outcome of these therapies. In a recent case series, data from patients with parkinsonism who underwent these procedures were collected retrospectively(31). … The report describes 17 patients with Parkinsonian syndromes who received intrathecal application of autologous unsorted bone marrow cells. There were no changes in motor function, activities of daily living, global clinical impression or antiparkinsonian medication after a median observation period of 10 months. Two patients (12%) reported a worsening of Parkinsonian symptoms, but the intervention was otherwise safe and well tolerated. Intrathecal application of autologous bone marrow cells in such uncontrolled conditions did not produce clinical benefit in these patients.”

I’ve copied the abstract to reference #31 below.

Of the 17 patients studied, 7 have a clinical diagnosis of PD, 7 have a clinical diagnosis of MSA, and 3 have other clinical diagnoses.  This break-down fits with my experience as well:  I’ve heard more about MSA patients trying out the various stem cell treatments available around the world than I’ve heard about those with PSP, CBD, or DLB diagnoses.  The reason may be that those with MSA are younger than those with the other diagnoses, on average, so there may be more desperation on the part of the patient and family.

We have had at least one person with MSA in our local support group who went to China for stem cell treatment.  And the medical advisor to our support group, Dr. Neng Huang, also reports that he knows of someone who went to China for stem cell treatment.  Neither patient seemed to have benefitted from the treatment.

I haven’t read the full article but presumably the 7 MSA patients don’t include those who participated in a South Korean study of autologous bone marrow cells (since clinical data was available in that case).

The MDS position paper can be found here:

www.movementdisorders.org/about/committees/stem-cell.php

There is a short lay summary in the position paper, and then a scientific summary that is three times as long.  I think most of you won’t have a problem reading the scientific summary!

Finally, here’s a link to the Movement Disorder Society’s short press release about the position paper:

www.movementdisorders.org/about/newsroom/release.php?contentid=1157

Robin

—————————————————————

Abstract

Movement Disorders. 2012 Oct;27(12):1552-5.  Epub 2012 Feb 23.

Intrathecal application of autologous bone marrow cell preparations in Parkinsonian syndromes.

Storch A, Csoti I, Eggert K, Henriksen T, Plate A, Lorrain M, Oertel WH, Antonini A.
Division of Neurodegenerative Diseases, Department of Neurology, Dresden University of Technology, Dresden, Germany.

BACKGROUND:
A growing number of patients is treated with intrathecal application of autologous bone marrow cells (aBMCs), but clinical data are completely lacking in movement disorders. We provide first clinical data on efficacy and safety of this highly experimental treatment approach in parkinsonian syndromes.

METHODS:
Retrospective data collection from patients with parkinsonism who spontaneously sought cell treatment. The application procedure was neither recommended nor performed by the authors.

RESULTS:
We report 17 patients with parkinsonian syndromes (Parkinson’s disease [PD], n = 7; multiple system atrophy [MSA], n = 7; various, n = 3) who received intrathecal application of aBMCs. We did not observe any changes in motor function, activities of daily living, global clinical impression, or antiparkinsonian medication after a median observation period of 10 months. Two patients reported a worsening of parkinsonian symptoms, but the intervention was otherwise safe and well-tolerated.

CONCLUSIONS:
Intrathecal application of aBMCs in uncontrolled conditions produces no clinical benefit in parkinsonian syndromes.

Copyright 2012 Movement Disorder Society.

PubMed ID#: 22362657

Poems by LBD Caregiver Wife

This week I saw some poems posted to the Link2Care list which were written by an LBD caregiver spouse who lives in San Luis Obispo.  Many of these poems will likely resonate with the spouses in our group but even we adult children can find parts that resonate with us.

The poet is Carol Pappas.  When I requested permission to share the poems, she replied:  “Yes, most certainly share the poems as my hope is they will be an encouragement to other caregivers on this same journey.  May it help with our sanity and longevity.”

Below, I’ve copied a few of her poems from July 17th and June 19th.

Robin

—————————————————————

Poems by Carol Pappas
July 17, 2013 (first 3) and June 19, 2013 (last one)

SPELLING TEST

It was 2002 when I learned
how to spell mastectomy.
A few years later
it was caregiver and
non-Hodgkin’s lymphoma.
Next came pacemaker,
dementia, and Lewy Body.
Finally in 2013 I learned
how to spell chauffeur
and also walk a slow gait.

CONVERSATION

Conversation with a dementia man
Needs psychic to know the subject,
Requires agreement of all,
No discussion allowed.

Conversation with a dementia man
Resembles a cat on a hot tin roof.

NEW LIFE

He calls me Hitler
and sometimes
monster
but never lovely
or beautiful.
My spirit longs
for meaningful
conversation
and love.
In another
season and time
with hope
will come
new life
and joy.

ALONE

i live with a dementia man
i am not by myself
yet so alone.

he is there with me
yet somewhere else.

we walk side by side
yet each alone.

each marching to the music
of a different tune.

our beat goes on
mine fast, his slow.

we are a world apart
in the drama of each day
each so alone.